Metabolic Protocol.
Rewrite your metabolism.
GLP-1 receptor agonist therapy for weight, insulin sensitivity, and metabolic health. Semaglutide or tirzepatide, titrated weekly based on tolerance and response. Eligible patients: BMI 27+ or type 2 diabetic.
Three mechanisms.
One outcome.
Regulates appetite
GLP-1 signals satiety in the brain. You eat less because you're not hungry — not because you're restricting.
Improves insulin
Slows gastric emptying and improves insulin sensitivity. Blood glucose stabilizes, energy more consistent throughout the day.
Compounds with habits
Most durable when paired with resistance training and protein-forward eating. Your clinician helps design the supporting habits.
Your stack.
Components prescribed and titrated by your clinician based on intake and labs. Not every patient gets every component — you receive what fits your profile.
The timeline.
Titration
Start at lowest dose. Mild nausea and fullness are common. Your clinician adjusts pace.
Weight drops
Average 8–12% bodyweight loss by week 12. Appetite is notably reduced.
Metabolic shift
Insulin sensitivity improves. Energy stabilizes. Body composition shifts toward lean mass.
Maintenance
Many taper to a lower maintenance dose. Others cycle off with habit support.
Answered.
Is this the same as Ozempic?+
Semaglutide is the active ingredient in Ozempic and Wegovy. We prescribe the same molecule, compounded at a 503A pharmacy, often at lower cost.
Will I lose muscle too?+
Some lean mass loss is normal during weight loss. Resistance training + high protein (1g/lb bodyweight) minimizes it.
What if I stop?+
Weight tends to return over 6–12 months if habits don't change. Protocol works best as a multi-year intervention, not a quick fix.
Side effects?+
Nausea, constipation, occasional fatigue during titration. Usually resolves within 2–4 weeks. Your clinician adjusts dose to minimize.
Toggle on Metabolic Protocol.
Start your intake.
Two minutes. Clinician reviews in 24 hours. You pay nothing until approved.